Publication: 4698

Publication: 4698

Clinical outcome of patients with sporadic vs Lynch syndrome-related stage III colon cancers with deficient mismatch repair (dMMR) treated in a randomized trial of adjuvant FOLFOX alone or combined with atezolizumab (Alliance A021502; ATOMIC).

Google Scholar

Citation:

Meeting Instance:: ESMO 2025
Year:: 2025
Type:: Abstract
Sub type:
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882

Corr. Author:
Authors:: Frank A. Sinicrope Fang-Shu Ou Dirk Arnold Robert J. Behrens Walter R. Peters Christopher Hanyoung Lieu Khalid Matin Deirdre J. Cohen Samara L Potter Yujia Wen Andrew W. Nixon Wendy L. Frankel Ardaman Shergill Dennis Hsu Anke C. Reinacher-Schick Tyler Zemla Clare A. Gatten Eileen M. O'Reilly Jeffrey A. Meyerhardt

Networks:: IWORC, LAPS-CO070, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC010, LAPS-NY016, LAPS-OH007, LAPS-PA015, NY021, TX012, VCU

Study: Alliance-A021502
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: